Osteoarthritis is not an autoimmune disease. It is a degenerative condition driven primarily by cartilage breakdown, mechanical stress, and low-grade inflammation, not by the immune system attacking healthy tissue. About 528 million people worldwide live with osteoarthritis, and the confusion with autoimmune arthritis is common because both cause joint pain, stiffness, and swelling. But the underlying processes are fundamentally different.
Why It Gets Confused With Autoimmune Arthritis
The main source of confusion is rheumatoid arthritis, which is an autoimmune disease. In rheumatoid arthritis, the immune system mistakenly attacks the tissues lining the joints, causing inflammation that can destroy cartilage and bone from the inside out. This is a systemic problem: it can affect organs beyond the joints, and it often strikes symmetrically on both sides of the body.
Osteoarthritis works differently. The protective cartilage on the ends of your bones wears down over time, making movement painful and difficult. Rather than your immune system launching an attack, the cartilage simply degrades faster than your body can repair it. Cells in the cartilage initially try to compensate by producing more of the structural proteins that hold the joint together, but as the disease progresses, those repair attempts get overwhelmed by ongoing breakdown.
Osteoarthritis Does Involve Inflammation
Here’s where things get nuanced. Osteoarthritis was long considered a purely “wear and tear” disease, but researchers now know that inflammation plays a real role in its progression. The key distinction is what kind of inflammation. In osteoarthritis, the inflammation is chronic, comparatively low-grade, and driven by the innate immune system (your body’s general first-response defenses) rather than the adaptive immune system that targets specific tissues in autoimmune diseases.
When cartilage breaks down, the debris triggers a cascade of inflammatory signals inside the joint. Tiny crystals released from damaged cartilage, fragments of structural proteins, and stress signals from injured cells all activate local inflammation. This creates a feedback loop: inflammation accelerates cartilage loss, which produces more debris, which fuels more inflammation. The joint fluid in osteoarthritis contains elevated levels of the same inflammatory molecules found in rheumatoid arthritis, just at lower concentrations and through a different mechanism.
This inflammatory component explains why osteoarthritis joints can swell, feel warm, and stiffen, symptoms people naturally associate with autoimmune conditions. But the inflammation is a consequence of joint damage, not the immune system going rogue.
How the Two Conditions Look Different
The joints each condition targets offer a practical clue. Osteoarthritis most commonly affects the knees (365 million people globally have knee osteoarthritis), followed by the hips and hands. In the hands, it tends to hit the joint closest to your fingertip. Rheumatoid arthritis usually spares that joint entirely, instead targeting the hands, wrists, and feet, and it typically appears in matching joints on both sides of the body.
Morning stiffness behaves differently too. In rheumatoid arthritis, stiffness often lasts an hour or more after waking. In osteoarthritis, stiffness tends to be shorter, though about 17% of people with hand osteoarthritis do experience prolonged morning stiffness, which is one reason the conditions can be hard to tell apart without imaging or blood work.
The demographics also diverge. Osteoarthritis is strongly age-related: about 73% of people living with it are older than 55. Roughly 60% are female. Rheumatoid arthritis can appear at any age, including in children, and its onset is often more sudden.
What Actually Causes Osteoarthritis
Because osteoarthritis isn’t autoimmune, its risk factors look very different. The major drivers are mechanical and metabolic rather than immunological.
- Age: Cartilage naturally loses its resilience over decades. The longer your joints bear weight and absorb impact, the more cumulative damage accumulates.
- Excess weight: Extra body weight puts significantly more stress on weight-bearing joints, especially the knees and hips. Beyond the mechanical load, fat tissue also produces inflammatory molecules called adipokines that can accelerate cartilage breakdown independently of joint stress.
- Joint injuries: A torn ACL, a fracture that extends into a joint, or repetitive occupational stress (frequent bending, squatting, or heavy lifting) all increase the risk of osteoarthritis in that specific joint later in life.
- Genetics: Some people inherit cartilage that is structurally less resilient, or joints that are shaped in ways that distribute force unevenly.
None of these involve immune dysfunction. They’re about the physical and biochemical environment inside the joint wearing down its protective structures over time.
Why Autoimmune Treatments Don’t Work for It
This distinction matters most when it comes to treatment. Rheumatoid arthritis is managed with drugs that suppress or redirect the immune system, slowing the attack on joint tissue. Researchers have tested these same drugs in osteoarthritis patients, and the results have been largely disappointing. The immune-suppressing medications that transform outcomes in rheumatoid arthritis produce inconsistent, modest effects in osteoarthritis.
The reason is molecular diversity. While immune activity contributes to osteoarthritis progression in some patients, other patients are driven more by cartilage degradation, bone remodeling, or tissue scarring. There is also significant variation in which types of immune cells show up in the joint tissue from person to person. This heterogeneity makes it difficult to find a single immune-targeted treatment that works broadly. Some clinical trials have shown benefits for specific subsets of patients, particularly those with knee or hand osteoarthritis, but researchers still lack reliable ways to identify which patients would respond.
Instead, osteoarthritis management focuses on reducing mechanical stress (weight management, physical therapy, activity modification), controlling pain and inflammation with anti-inflammatory medications, and in advanced cases, joint replacement surgery. These approaches target the actual drivers of the disease rather than the immune system.
The Bottom Line on Classification
Osteoarthritis sits in its own category: a degenerative joint disease with an inflammatory component, but not an autoimmune one. The immune system participates in its progression the way it participates in any tissue injury, by responding to damage signals and sometimes making things worse. But it is not the cause. Your body is not mistaking your joints for a threat. The cartilage is breaking down because of accumulated wear, metabolic stress, or prior injury, and inflammation follows as a secondary process rather than leading the charge.